We are live on ! Find out more
VIA

Virtus Investment Advisers Portfolio holdings

AUM $363M
1-Year Est. Return 34.89%
This Fund
S&P 500
This Quarter Est. Return
+5.04%
1 Year Est. Return
+34.89%
3 Year Est. Return
+131.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$363M
AUM Growth
-$5.41M
Cap. Flow
+$2.38M
Cap. Flow %
0.66%
Top 10 Hldgs %
7.17%
Holding
495
New
34
Increased
285
Reduced
131
Closed
45

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.11M
2
HSY icon
Hershey
HSY
+$2.09M
3
GILD icon
Gilead Sciences
GILD
+$2.07M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.05M
5
EIX icon
Edison International
EIX
+$2.04M

Top Sells

Rank Stock Value
1
HBAN icon
Huntington Bancshares
HBAN
+$2.13M
2
TKO icon
TKO Group
TKO
+$2.13M
3
WAT icon
Waters Corp
WAT
+$2.09M
4
STT icon
State Street
STT
+$2.07M
5
AON icon
Aon
AON
+$2.04M

Sector Composition

Rank Sector Weight
1 Healthcare 31.87%
2 Financials 20.97%
3 Technology 10.66%
4 Industrials 10.62%
5 Consumer Discretionary 7.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATAI icon
326
AtaiBeckley Inc
ATAI
$2.66B
$225K 0.06%
+63,563
New +$239K
CMPS
327
Compass Pathways
CMPS
$1.52B
$224K 0.06%
40,457
+986
+2% +$6.63K
NRIX icon
328
Nurix Therapeutics
NRIX
$2.43B
$222K 0.06%
14,299
+350
+3% +$5.8K
PROK icon
329
ProKidney
PROK
$308M
$221K 0.06%
123,388
+3,012
+3% +$6.39K
XERS icon
330
Xeris Biopharma Holdings
XERS
$1.44B
$221K 0.06%
38,030
+928
+3% +$6.15K
VERA icon
331
Vera Therapeutics
VERA
$2.54B
$220K 0.06%
5,474
+132
+2% +$5.69K
EYPT icon
332
EyePoint Inc
EYPT
$1.02B
$220K 0.06%
17,052
+414
+2% +$6.19K
SVRA icon
333
Savara
SVRA
$1.13B
$215K 0.06%
39,405
+962
+3% +$5.36K
AU icon
334
AngloGold Ashanti
AU
$40.3B
$214K 0.06%
2,199
+392
+22% +$40.2K
TSHA icon
335
Taysha Gene Therapies
TSHA
$1.59B
$211K 0.06%
47,095
+1,149
+3% +$5.34K
ASMB icon
336
Assembly Biosciences
ASMB
$506M
$210K 0.06%
7,553
+184
+2% +$5.25K
MAZE
337
Maze Therapeutics
MAZE
$1.53B
$209K 0.06%
7,016
+170
+2% +$7.5K
CBT icon
338
Cabot Corp
CBT
$4.65B
$207K 0.06%
2,750
+275
+11% +$20K
MUR icon
339
Murphy Oil
MUR
$5.58B
$207K 0.06%
5,007
-122
-2% -$4.13K
SLVM icon
340
Sylvamo
SLVM
$1.52B
$206K 0.06%
4,873
+1,557
+47% +$72.9K
REPL icon
341
Replimune Group
REPL
$814M
$205K 0.06%
26,786
+653
+2% +$4.99K
APA icon
342
APA Corp
APA
$12.8B
$205K 0.06%
4,825
-1,836
-28% -$55.5K
CRC icon
343
California Resources
CRC
$4.75B
$204K 0.06%
2,950
-784
-21% -$44.4K
BP icon
344
BP
BP
$113B
$203K 0.06%
4,322
-441
-9% -$17.3K
WLK icon
345
Westlake Corp
WLK
$9.46B
$203K 0.06%
1,736
-450
-21% -$43.6K
SXC icon
346
SunCoke Energy
SXC
$757M
$202K 0.06%
31,071
+8,330
+37% +$58.9K
MTDR icon
347
Matador Resources
MTDR
$6.31B
$202K 0.06%
3,200
-678
-17% -$34K
SM icon
348
SM Energy
SM
$7.96B
$202K 0.06%
6,482
-2,080
-24% -$47.5K
PR
349
Permian Resources
PR
$17.9B
$202K 0.06%
9,453
-2,095
-18% -$36.2K
CVE icon
350
Cenovus Energy
CVE
$54.6B
$202K 0.06%
7,596
-2,129
-22% -$45.4K
12 13
14
15 16

Similar funds

RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
HS
HighVista Strategies Boston, Massachusetts $362M AUM 230.96% 1-Year Est. Return
SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
MA
Modus Advisors Excelsior, Minnesota $363M AUM 22.99% 1-Year Est. Return

Virtus Investment Advisers's Q1 2026 Portfolio in Review

As of Q1 2026, Virtus Investment Advisers held 495 positions worth $363M, down 1.5% from $368M the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

Virtus Investment Advisers's Q1 2026 filing shows 34 new, 285 increased, 131 reduced and 45 closed positions. Its largest new stake was Hershey: 9,903 shares worth $2.06M. The largest sale was Huntington Bancshares, an estimated $2.13M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 27% a quarter earlier, followed by Financials and Technology.

  • Virtus Investment Advisers's largest Q1 2026 buy was Hershey: 9,903 shares worth $2.06M.
  • Virtus Investment Advisers added most to Amgen in Q1 2026, an estimated $2.11M increase.
  • Virtus Investment Advisers's biggest Q1 2026 reduction was Micron Technology, cutting an estimated $1.56M.
  • Virtus Investment Advisers fully exited Huntington Bancshares in Q1 2026, selling an estimated $2.13M.
  • Virtus Investment Advisers's ten largest holdings make up 7.2% of its $363M portfolio in Q1 2026.
  • Virtus Investment Advisers opened 34 new positions and closed 45 in Q1 2026.
  • Virtus Investment Advisers's portfolio value fell 1.5% quarter-over-quarter to $363M.

Based on Virtus Investment Advisers's 13F filing for Q1 2026, filed 14 May 2026.